Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections
- 1 February 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 148 (2) , 343-348
- https://doi.org/10.1001/archinte.148.2.343
Abstract
Research from JAMA Internal Medicine — Blinded Comparison of Cefuroxime to Cefaclor for Lower Respiratory Tract InfectionsThis publication has 13 references indexed in Scilit:
- Pharmacokinetics and bactericidal activity of cefuroxime axetilAntimicrobial Agents and Chemotherapy, 1985
- Single-dose Cefuroxime Axetil in the Treatment of Uncomplicated Gonorrhea: A Controlled TrialSexually Transmitted Diseases, 1985
- Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infectionJournal of Antimicrobial Chemotherapy, 1985
- A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 1985
- In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strainsAntimicrobial Agents and Chemotherapy, 1985
- CLINICAL AND MICROBIOLOGICAL FEATURES OF BRANHAMELLA CATARRHALIS BRONCHOPULMONARY INFECTIONSThe Lancet, 1984
- Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosingAntimicrobial Agents and Chemotherapy, 1984
- Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteersAntimicrobial Agents and Chemotherapy, 1984
- Cefuroxime, Cefamandole, Cefoxitin, and Cephalothin In Vitro Susceptibility Tests: Reassessment of the “Class Representative” Concept, Confirmation of Disk Interpretive Criteria, and Proposed Quality Control GuidelinesAmerican Journal of Clinical Pathology, 1983
- ANTIBIOTIC SUSCEPTIBILITY TESTING BY A STANDARDIZED SINGLE DISK METHOD1966